|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||67.88 / 92.85|
The pharmaceutical giant tapped a 20-year company veteran to succeed John Lechleiter, who will retire as president and CEO at yearend.
TheStreet highlights 3 stocks pushing the drugs industry higher today.
Eli Lilly (LLY) announced the resignation of CEO John Lichleiter at the end of 2016.
A TauRx Therapeutics drug designed to dissolve tangles of a protein called tau in the brain failed to slow cognitive and functional declines of Alzheimer's patients compared with a control.
U.S. stocks retreat into the red as a number of positive and negative earnings reports keep trading choppy.
Stocks trade mixed Tuesday as a number of positive and negative earnings report keep traders active.
CEO of the drug manufacturing company Eli Lilly (LLY), John Lechleiter, joined CNBC's "Squawk Box" this morning to discuss the company's second quarter earnings.
Eli Lilly (LLY) stock is increasing in pre-market trading this morning after the pharmaceutical company posted mixed second quarter results before Tuesday's opening bell.
Stock futures are mixed as investors stay on the sidelines ahead of the kickoff to the Federal Reserve's July meeting.
Eli Lilly reports earnings on Tuesday. The stock could continue to rise, as the company has several catalysts on the horizon.
Optimism is warranted over the long haul, but investors probably face a short-term headache. Here are the crucial numbers and events to watch in the week ahead.
The Federal Reserve will steal focus from another onslaught of earnings in the coming week as investors remain wary over the central bank's rate-hike timetable.
BMO Capital Markets downgrades the pharmaceutical giant ahead of Q2 earnings as pricing pressure mounts and other potential headwinds begin to emerge.
Mike Pence could shore up Donald Trump's support among conservative Christians, but his record on business in Indiana is spotty at best.
TheStreet highlights 3 stocks pushing the health care sector higher today.
Unique program addresses industry's lack of underrepresented minorities
Stocks with insider trader activity include APOG, LLY and SNCR
Cramer has learned what works and what doesn't at Action Alerts PLUS. Here's how his thinking can help you profit.
The charts look favorable for these six high-yield dividend stocks. The stocks are among Deutsche Bank's list of best long ideas.
The company's shares were up nearly 2% in after hours trading.
Singer's moving story aims to help inspire children with type 1 diabetes to pursue their dreams
Following Brexit volatility, Deutsche Bank offered investors 42 best long ideas; here's the 12 stocks from the list with the highest dividend yields.
Nike's board of directors features a who's who of Fortune 500 executives.
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
If Eli Lilly can blow through the $79 area, the stock has plenty of room to run on the upside.
Besides Sanofi, Biogen is the next most likely to complete a sizable transaction in the next 12 months, according to Credit Suisse analysts.